EnviroCair®-AV
helps prevent spread of Avian Influenza (bird flu) H5N1
• Tested by Professor John Oxford's Retroscreen laboratory at Queen Mary Medical School, University of London
• Specifically tested against H5N1 with 99.97% reduction in virus
• Effective broad spectrum disinfectant targeting Avian Influenza (bird flu)
• Easily distributed using fogging machine or introduced into air conditioning
systems
• designed for use in transport systems such as underground and rail carriages and buses
• Can be used in range of buildings including poultry houses, commercial buildings, offices, hotels, arena, airports
• Non-corrosive and non-toxic
click here to see full Retroscreen report on antiviral acivity of EnviroCair against NIBRG-14 (H5N1) virus
Bird flu protection for homes and offices
EnviroCair wall-mounted air diffuser can give continuous protection against a range of pathogens including bird flu
 |
return to PRODUCTS
Flu pandemic: new doubts over key drug
Studies show resistance to Tamiflu
Sarah Boseley, health editor
Thursday December 22, 2005
The Guardian
Serious questions are raised today about the ability to combat an anticipated bird flu pandemic following the deaths of two people who were being treated with the drug the world is stockpiling as a safeguard against the virus.